(Credit: Ermolaev Alexander/Shutterstock) Sign up for our email newsletter for the latest science news For Parkinsons patients, deep brain stimulation (DBS) can help control a number of neurological symptoms, like muscle spasms and stiffness. But one weird side effect has surfaced in a string of case studies: Some patients, no matter how good their motor skills, lose their ability to swim after the procedure. Researchers from the University of Zrich in Switzerland published a report today in Neurology identifying nine cases where patients couldnt stay afloat after DBS. Continue reading →

Sunovion has resubmitted the New Drug Application (NDA) for apomorphine sublingual film (APL-130277) to the Food and Drug Administration (FDA) for the treatment of motor fluctuations, or OFF episodes, experienced by patients with Parkinson disease (PD). The sublingual film is a novel formulation of apomorphine, a dopamine agonist. It is designed for use as a fast-acting on-demand treatment for all types of motor OFF episodes (morning OFF, unpredictable OFF, and end-of-dose wearing OFF) up to 5 times a day. Continue reading →

A twitch is a small, involuntary contraction and relaxation of a muscle or group of muscles. The medical term for twitches is "fasciculations," and they can occur in any muscular area, including the fingers. People with finger twitching may worry that they are developing a neurological disorder. Continue reading →

Where does Parkinsons disease (PD) begin? In the brain or in the gut? According to new findings, both are possibilities Continue reading →

27 Nov 2019 Twenty years ago, researchers took fibroblasts from the skin of eight Alzheimers patients, engineered them to produce nerve-growth factor, and slid them into each volunteers basal forebrain. They hoped the neurotrophin would halt or slow the neurodegeneration that robbed them of their memories, indeed their lives. Continue reading →

The Parkinsons Disease Treatment Market report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Continue reading →

SAN DIEGO--(BUSINESS WIRE)-- - ACADIA to initiate second pivotal study in the first half of 2020 - Conference call and webcast to be held today at 5:00 p.m. Eastern Time ACADIA Pharmaceuticals Inc. Continue reading →